https://unaopcionparati.roche.com.mx2026-01-12https://unaopcionparati.roche.com.mx/es/trials.html2025-06-06https://unaopcionparati.roche.com.mx/es/trials/uncategorized.html2023-05-08https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-paclitaxel-as-a-treat.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-comparing-atezolizumab--anti-pd-l1-antibody--in-68166.html2025-05-26https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-to-evaluate-the-pharmacokinetics--efficacy--and-safety-o.html2024-06-27https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-pertuzumab-in-addition-to-chemotherapy-and-trastuzuma.html2020-05-21https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-the-efficacy-and-safety-of-atezolizumab-plus-chemothe.html2025-11-13https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-to-evaluate-patient-preference-and-satisfaction-26388.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-trastuzumab-emtansine-versus-trastuzumab-as-adjuvant-.html2025-07-01https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-atezolizumab-93464.html2024-09-24https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-trastuzumab-emtansine--kadcyla--plus-pertuzu-91245.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-pertuzumab-in-combination-with-trastuzumab---50542.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-atezolizumab--tecentriq--plus-nab-paclitaxel-22823.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--70278.html2025-06-02https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-9545--28702.html2025-06-03https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-04316.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-of-ro7247669---nab-paclitaxel-compared-with-pem-15706.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-to-evaluate-efficacy-and-safety-of-giredestrant-50902.html2025-11-18https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/the-purpose-of-this-study-is-to-evaluate-the-efficacy-a-74702.html2025-11-06https://unaopcionparati.roche.com.mx/es/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-81795.html2025-11-11https://unaopcionparati.roche.com.mx/es/trials/cancer/leukemia.html2019-03-11https://unaopcionparati.roche.com.mx/es/trials/cancer/oc.html2021-04-30https://unaopcionparati.roche.com.mx/es/trials/cancer/cca/a-study-of-tiragolumab-plus-atezolizumab-and-atezolizum-32500.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/pv.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/bladder-cancer/study-of-atezolizumab-as-monotherapy-and-in-combination-with-pla.html2025-02-25https://unaopcionparati.roche.com.mx/es/trials/cancer/bladder-cancer/a-study-of-atezolizumab-versus-placebo-as-adjuvant-ther-94959.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/bladder-cancer/a-study-of-ro7247669-alone-or-in-combination-with-tirag-35445.html2025-08-05https://unaopcionparati.roche.com.mx/es/trials/cancer/bladder-cancer/a-study-to-evaluate-the-efficacy-and-safety-of-autogene-25008.html2025-09-05https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-of-atezolizumab-compared-with-chemotherapy-in-treatment-.html2024-10-24https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-to-evaluate-efficacy-and-safety-of-multiple-targeted-the.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-of-carboplatin-plus-etoposide-with-or-without-atezolizum.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-44503.html2025-05-27https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-to-investigate-the-pharmacokinetics--efficacy---50110.html2025-06-02https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-98469.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-to-compare-the-efficacy-and-safety-of-entrectin-60665.html2025-11-05https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-phase-iii--open-label-study-of-maintenance-lurbinecte-08813.html2025-10-23https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-of-ro7247669-plus-platinum-based-chemotherapy-v-60649.html2025-11-20https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-divarasib-87627.html2025-11-13https://unaopcionparati.roche.com.mx/es/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-multiple--44971.html2025-11-10https://unaopcionparati.roche.com.mx/es/trials/cancer/multiple-myeloma.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/rcc/a-study-of-atezolizumab-plus-bevacizumab-versus-active--52983.html2025-04-21https://unaopcionparati.roche.com.mx/es/trials/cancer/skin-cancer.html2019-07-26https://unaopcionparati.roche.com.mx/es/trials/cancer/hepatocellular-carcinoma/a-study-evaluating-atezolizumab-and-bevacizumab--with-o-66135.html2025-11-25https://unaopcionparati.roche.com.mx/es/trials/cancer/Head_and_Neck_Cancer.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/Brain_Tumor.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/pancreatic-cancer.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/gc.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/an-extension-study-to-provide-continued-bevacizumab-therapy-to-p.html2024-08-30https://unaopcionparati.roche.com.mx/es/trials/cancer/fmi.html2026-02-20https://unaopcionparati.roche.com.mx/es/trials/cancer/alk-rearranged-non-small-cell-lung-cancer.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety-and-efficacy-of-polatuzu-71789.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/cancer/non-hodgkins-lymphoma/an-open-label-study-comparing-glofitamab-and-polatuzuma-51322.html2025-10-03https://unaopcionparati.roche.com.mx/es/trials/cancer/solid-tumors/screening-study-for-participants-with-malignant-tumors-95723.html2025-11-06https://unaopcionparati.roche.com.mx/es/trials/cancer/a-rollover-study-for-participants-previously-enrolled-i-26392.html2025-11-19https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/giant-cell-arteritis.html2020-08-14https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/jia/a-study-of-decreased-dose-frequency-in-participants-with-systemi.html2024-08-30https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/jia/a-study-of-subcutaneously--sc--administered-tocilizumab-80633.html2024-06-22https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/jia/a-study-of-subcutaneously-administered-tocilizumab-in-p-36947.html2024-06-22https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/ra/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-gdc-085.html2025-06-12https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/sjogren-s-syndrome.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-with-ad.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-the-efficacy-and-safety-of-induction--32899.html2025-11-25https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/sle/study-of-the-safety-and-efficacy-of-gdc-0853-in-participants-wit.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/sle/study-of-the-safety-and-efficacy-of-gdc-0853-in-participants-wit1.html2020-03-11https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-62318.html2025-10-09https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/sle/a-first-in-human-study-to-investigate-the-safety--toler-46873.html2025-11-18https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-induction--79083.html2025-11-25https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-ro7790121--09855.html2025-11-22https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-33293.html2025-11-07https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-25573.html2025-11-11https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/a-clinical-trial-of-omalizumab-in-participants-with-chronic-rhin.html2025-06-12https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/a-clinical-trial-of-omalizumab-in-participants-with-chronic-rhin0.html2025-06-12https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/an-extension-study-of-omalizumab-in-participants-with-chronic-rh.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy-and-safety-of-ocrelizu-22490.html2025-04-23https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/multiple-sclerosis/a-pharmacokinetics--pk---pharmacodynamics--pd---safety--83549.html2026-01-16https://unaopcionparati.roche.com.mx/es/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-assess-bioequivalence-of-two-subcutaneous--s-18385.html2025-11-26https://unaopcionparati.roche.com.mx/es/trials/eye-disorder/glaucoma.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/eye-disorder/amd.html2026-02-20https://unaopcionparati.roche.com.mx/es/trials/eye-disorder/amd/a-study-to-evaluate-the-long-term-safety-and-tolerabili-60381.htmlhttps://unaopcionparati.roche.com.mx/es/trials/eye-disorder/wamd/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-34628.html2024-08-30https://unaopcionparati.roche.com.mx/es/trials/muscle-and-peripheral-nerve-disease.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/muscle-and-peripheral-nerve-disease/sma.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/muscle-and-peripheral-nerve-disease/dmd.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/muscle-and-peripheral-nerve-disease/muscular-dystrophy.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/hbv.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/hbv/a-trial-to-evaluate-the-efficacy-and-safety-of-multiple-42976.htmlhttps://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/influenza/study-to-assess-efficacy-and-safety-of-baloxavir-marbox-94137.html2024-09-01https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/influenza/study-to-assess-the-efficacy-of-baloxavir-marboxil-vers-02272.html2024-09-01https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/bacterial-infection.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-efficacy-and-safety-of-tocilizu-42486.html2024-08-30https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-safety-and-efficacy-of-mstt1041-69681.html2024-09-01https://unaopcionparati.roche.com.mx/es/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-efficacy-and-safety-of-tocilizu-424861.html2021-01-29https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/ad/safety-and-efficacy-study-of-gantenerumab-in-participants-with-e.html2024-06-22https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/ad/cread-study--a-study-of-crenezumab-versus-placebo-to-ev-21662.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety-and-tolerability-of-long-88018.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety--tolerability--and-effic-66535.html2024-08-31https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/als.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/pd.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/study-to-evaluate-the-effectiveness-and-safety-of-ocrelizumab-in.html2025-01-16https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-to-evaluate-ocrelizumab-treatment-in-participants-with-p.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy-and-safety-of-fenebrut-03470.html2025-04-21https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy--safety-and-pharmacoki-18428.html2025-03-27https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/study-to-evaluate-the-efficacy-and-safety-of-fenebrutin-78378.html2025-04-21https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-of-ocrelizumab-in-participants-with-primary-pro-36628.htmlhttps://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/multiple-sclerosis/a-rollover-study-to-evaluate-the-long-term-safety-and-e-52490.html2025-05-05https://unaopcionparati.roche.com.mx/es/trials/neurodegenerative-disorder/hd.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/neurodevelopmental-disorder.html2020-08-14https://unaopcionparati.roche.com.mx/es/trials/neurodevelopmental-disorder/autism-spectrum-disorder.html2020-08-14https://unaopcionparati.roche.com.mx/es/trials/psychiatric-disorder.html2019-03-11https://unaopcionparati.roche.com.mx/es/trials/psychiatric-disorder/schizophrenia.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/respiratory-disorder.html2019-03-11https://unaopcionparati.roche.com.mx/es/trials/respiratory-disorder/ipf.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/respiratory-disorder/respiratory-other.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/respiratory-disorder/asthma.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/healthy-volunteers.html2019-03-11https://unaopcionparati.roche.com.mx/es/trials/kidney-disorder/ckd.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/kidney-disorder/renal-failure.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/kidney-disorder/iga-nephropathy/a-study-to-evaluate-the-efficacy-and-safety-of-ro743465-06097.html2025-10-25https://unaopcionparati.roche.com.mx/es/trials/metabolic-disorder/t1d.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/metabolic-disorder/t2d.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/metabolic-disorder/Liver_Failure.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/metabolic-disorder/obesity/a-study-of-ct-388-in-participants-who-are-overweight-or-91515.html2025-10-08https://unaopcionparati.roche.com.mx/es/trials/hematologic-diseases/myelodysplastic-syndrome.html2018-12-20https://unaopcionparati.roche.com.mx/es/trials/hematologic-diseases/Hemophilia/hemophilia-a/a-study-to-evaluate-the-safety-and-tolerability-of-prophylactic-.html2024-08-30https://unaopcionparati.roche.com.mx/es/trials/blood-disorder/atypical-hemolytic-uremic-syndrome/a-study-evaluating-the-efficacy--safety--pharmacokineti-90194.html2025-04-30https://unaopcionparati.roche.com.mx/es/trials/blood-disorder/atypical-hemolytic-uremic-syndrome/a-study-evaluating-the-efficacy--safety--pharmacokineti-29406.html2025-10-25https://unaopcionparati.roche.com.mx/es/faq.html2023-11-15https://unaopcionparati.roche.com.mx/es/faq/what-is-a-clinical-trial.html2023-09-14https://unaopcionparati.roche.com.mx/es/faq/why-should-i-consider-taking-part-in-a-clinical-trial.html2020-08-06https://unaopcionparati.roche.com.mx/es/faq/roche-in-clinical-trials.html2023-11-15https://unaopcionparati.roche.com.mx/es/faq/what-is-a-clinical-trial1.html2021-08-09https://unaopcionparati.roche.com.mx/es/faq/advancing-inclusive-research.html2023-08-28https://unaopcionparati.roche.com.mx/es/faq/what-is-an-observational-trial.html2023-08-28https://unaopcionparati.roche.com.mx/es/error.html2018-11-21https://unaopcionparati.roche.com.mx/es/error/404.html2024-10-18https://unaopcionparati.roche.com.mx/es/error/403.html2024-10-18https://unaopcionparati.roche.com.mx/es/error/500.html2024-10-18https://unaopcionparati.roche.com.mx/es/privacy-policy.html2018-11-21https://unaopcionparati.roche.com.mx/es/glossary-terms.html2019-06-06https://unaopcionparati.roche.com.mx/es/About.html2023-11-15https://unaopcionparati.roche.com.mx/es/CovidMX.html2020-04-28https://unaopcionparati.roche.com.mx/es/sitemap.html2018-11-21https://unaopcionparati.roche.com.mx/es/disease-area-overview.html2021-04-16https://unaopcionparati.roche.com.mx/es/a-note-about-covid-19.html2023-09-04https://unaopcionparati.roche.com.mx/es/new-solr-search.html2024-02-15